These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Effects of the muscarinic agonist McN-A-343 on responses to sympathetic nerve stimulation in the rabbit ear artery. Rand MJ; Varma B Br J Pharmacol; 1971 Nov; 43(3):536-42. PubMed ID: 5157721 [TBL] [Abstract][Full Text] [Related]
48. The blood pressure response to dimethylphenylpiperazinium iodide in the rat. Chinn C; Weber LJ Proc West Pharmacol Soc; 1968; 11():106-7. PubMed ID: 5734464 [No Abstract] [Full Text] [Related]
49. Atropine-resistant effects of the muscarinic agonists McN-A-343 and AHR 602 on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Fozard JR; Muscholl E Br J Pharmacol; 1974 Apr; 50(4):531-41. PubMed ID: 4447857 [TBL] [Abstract][Full Text] [Related]
50. Muscarinic receptor agonist-antagonist interaction in the rat rectum: are there ways of activating the same receptors? Akah PA; Oriowo MA J Pharm Pharmacol; 1985 Aug; 37(8):589-92. PubMed ID: 2864428 [TBL] [Abstract][Full Text] [Related]
51. Functional activity of the sweat glands of the mouse. Hayashi H Tohoku J Exp Med; 1968 Jul; 95(3):289-95. PubMed ID: 5707901 [No Abstract] [Full Text] [Related]
52. The need for calcium in adrenomedullary secretion evoked by biogenic amines, polypeptides, and muscarinic agents. Poisner AM; Douglas WW Proc Soc Exp Biol Med; 1966 Oct; 123(1):62-4. PubMed ID: 4288626 [No Abstract] [Full Text] [Related]
53. Influence of cholinergic agents on dopamine release from medial basal hypothalamus. Perkins NA; Westfall TC Neurosci Lett; 1979 Mar; 11(3):283-7. PubMed ID: 92774 [TBL] [Abstract][Full Text] [Related]
54. The antagonism between cholinomimetic agonists and beta-adrenoceptor stimulants. The differentiation between functional and metaffinoid antagonism. Offermeier J; van den Brink FG Eur J Pharmacol; 1974 Jul; 27(2):206-13. PubMed ID: 4153104 [No Abstract] [Full Text] [Related]
55. Comparison of the effects of the intranigral injections of cholinomimetics with systemic injections of the dopamine receptor stimulating and blocking agents in the rabbit. Wolfarth S; Dulska E; Lacki M Neuropharmacology; 1974 Sep; 13(9):867-75. PubMed ID: 4473750 [No Abstract] [Full Text] [Related]
56. Hypothalamic superfusion with muscarinic drugs: their effects on pressor responses to hypothalamic stimulation. Philippu A; Bohuschke N Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):1-7. PubMed ID: 934350 [TBL] [Abstract][Full Text] [Related]
57. Muscarinic cholinergic stimulation of phosphatidylinositol turnover in isolated rat superior cervical sympathetic ganglia. Lapetina EG; Brown WE; Michell RH J Neurochem; 1976 Mar; 26(3):649-51. PubMed ID: 177736 [No Abstract] [Full Text] [Related]
58. [Pharmacological analysis of the inhibition of peristalsis of the isolated guinea-pig ileum by tetramethylammonium]. Beleslin D; Samardzić R; Malobabić Z C R Seances Soc Biol Fil; 1976; 170(2):331-5. PubMed ID: 134800 [TBL] [Abstract][Full Text] [Related]
59. Cholinergic control of cochlear blood flow. Suga F; Snow JB Ann Otol Rhinol Laryngol; 1969 Oct; 78(5):1081-90. PubMed ID: 5822991 [No Abstract] [Full Text] [Related]
60. The stimulation of canine prostatic secretion by substances with ganglion-stimulating actions. Smith ER; Ilievski V Proc Soc Exp Biol Med; 1969 Feb; 130(2):667-71. PubMed ID: 5765317 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]